Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2) (CRESCENT2)
Primary Purpose
Stable Angina Pectoris, Coronary Artery Disease
Status
Completed
Phase
Phase 3
Locations
Netherlands
Study Type
Interventional
Intervention
Cardiac CT scan
Sponsored by
About this trial
This is an interventional diagnostic trial for Stable Angina Pectoris focused on measuring Computed tomography, Coronary angiography, Coronary artery disease, Perfusion imaging, Comparative effectiveness, Randomized controlled trial, Cost-effectiveness
Eligibility Criteria
Inclusion Criteria:
- Men and women aged >18 years.
- Chest pain symptoms suspicious of coronary heart disease.
- Pre-test probability of coronary artery disease >10%
Exclusion Criteria:
- History of CAD: prior myocardial infarction or revascularization procedure
- Contra-indication to radiation exposure (CT/SPECT): pregnancy
- Contra-indication to iodine contrast media: renal failure, iodine allergy
- Contra-indications to adenosine
- Inability or unwillingness to provide informed consent.
Sites / Locations
- Albert Schweizerzieknhuis
- Maastricht University Medical Center
- Erasmus MC
- Maasstadziekenhuis
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Comprehensive cardiac CT
Standard care
Arm Description
Tiered cardiac CT protocol: CT calcium scan CT angiography (if calcium scan positive or high pre-test probability) CT perfusion (if >50% stenosis on CTA, or cannot be ruled out)
Standard diagnostic management of suspected CAD, using stress testing
Outcomes
Primary Outcome Measures
Rate of negative invasive angiograms (as percentage of total population)
Number of performed invasive angiograms with no CAD requiring intervention
Secondary Outcome Measures
Chest pain complaints
Proportion of patients experiencing symptoms of chest pain
Quality of life
Questionnaire based quality of life score
Major adverse event rate
Death, myocardial infarction, unstable angina, urgent revascularizations, CVA
Radiation exposure
Cumulative radiation dose from diagnostic and therapeutic interventions
Number of diagnostic and therapeutic procedures
Number of diagnostic and therapeutic procedures
Medical expenses
All medical expenses related to the diagnosis and treatment of suspected CAD
Full Information
NCT ID
NCT02291484
First Posted
November 11, 2014
Last Updated
August 3, 2016
Sponsor
Erasmus Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT02291484
Brief Title
Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)
Acronym
CRESCENT2
Official Title
Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
August 2013 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Erasmus Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Multi-center, randomized-controlled trial comparing a comprehensive cardiac CT protocol with standard stress testing in patients with stable chest pain complaints.
Detailed Description
Rationale: CT calcium and coronary lumen imaging allow efficient exclusion of coronary artery disease (CAD), but cannot assess the hemodynamic significance of obstructive findings. Addition of stress myocardial perfusion imaging, which assesses the functional relevance of coronary narrowing, completes the non-invasive cardiac evaluation.
Hypothesis: A comprehensive cardiac CT examination will allow fast, accurate and complete evaluation of suspected CAD.
Objective: evaluate the effectiveness and efficiency of comprehensive cardiac CT workup of suspected CAD.
Study design: Open-labelled, randomized-controlled, clinical efficiency trial, with an intention-to-diagnose approach, between CT-guided management and the current standard of care (based on functional testing of provocable myocardial ischemia) in patients with suspected CAD.
Study population: 250 patients (>18 yrs) with stable chest complaints, a >10% pre-test probability of CAD, and referred for evaluation of possible CAD.
Intervention: Instead of the usual diagnostic approach, patients in the intervention group will undergo in sequence the following CT examinations: coronary calcium scan, coronary CT angiography and CT myocardial perfusion imaging, with completion dependent on results. Findings on CT will direct further management.
Main study parameters/endpoints:
Primary: Rate of negative invasive angiograms (as percentage of total population) Secondary: Diagnostic yield, chest complaints, quality of life, diagnostic and therapeutic procedures, overall costs and adverse events at 6 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stable Angina Pectoris, Coronary Artery Disease
Keywords
Computed tomography, Coronary angiography, Coronary artery disease, Perfusion imaging, Comparative effectiveness, Randomized controlled trial, Cost-effectiveness
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
250 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Comprehensive cardiac CT
Arm Type
Experimental
Arm Description
Tiered cardiac CT protocol:
CT calcium scan
CT angiography (if calcium scan positive or high pre-test probability)
CT perfusion (if >50% stenosis on CTA, or cannot be ruled out)
Arm Title
Standard care
Arm Type
No Intervention
Arm Description
Standard diagnostic management of suspected CAD, using stress testing
Intervention Type
Device
Intervention Name(s)
Cardiac CT scan
Intervention Description
CT-guided management
Primary Outcome Measure Information:
Title
Rate of negative invasive angiograms (as percentage of total population)
Description
Number of performed invasive angiograms with no CAD requiring intervention
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Chest pain complaints
Description
Proportion of patients experiencing symptoms of chest pain
Time Frame
6 months
Title
Quality of life
Description
Questionnaire based quality of life score
Time Frame
6 months
Title
Major adverse event rate
Description
Death, myocardial infarction, unstable angina, urgent revascularizations, CVA
Time Frame
6 months
Title
Radiation exposure
Description
Cumulative radiation dose from diagnostic and therapeutic interventions
Time Frame
6 months
Title
Number of diagnostic and therapeutic procedures
Description
Number of diagnostic and therapeutic procedures
Time Frame
6 months
Title
Medical expenses
Description
All medical expenses related to the diagnosis and treatment of suspected CAD
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Men and women aged >18 years.
Chest pain symptoms suspicious of coronary heart disease.
Pre-test probability of coronary artery disease >10%
Exclusion Criteria:
History of CAD: prior myocardial infarction or revascularization procedure
Contra-indication to radiation exposure (CT/SPECT): pregnancy
Contra-indication to iodine contrast media: renal failure, iodine allergy
Contra-indications to adenosine
Inability or unwillingness to provide informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Koen Nieman, MD, PhD
Organizational Affiliation
Erasmus Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Albert Schweizerzieknhuis
City
Dordrecht
ZIP/Postal Code
3318 AT
Country
Netherlands
Facility Name
Maastricht University Medical Center
City
Maastricht
ZIP/Postal Code
6229 HX
Country
Netherlands
Facility Name
Erasmus MC
City
Rotterdam
ZIP/Postal Code
3015CE
Country
Netherlands
Facility Name
Maasstadziekenhuis
City
Rotterdam
Country
Netherlands
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
29248657
Citation
Lubbers M, Coenen A, Kofflard M, Bruning T, Kietselaer B, Galema T, Kock M, Niezen A, Das M, van Gent M, van den Bos EJ, van Woerkens L, Musters P, Kooij S, Nous F, Budde R, Hunink M, Nieman K. Comprehensive Cardiac CT With Myocardial Perfusion Imaging Versus Functional Testing in Suspected Coronary Artery Disease: The Multicenter, Randomized CRESCENT-II Trial. JACC Cardiovasc Imaging. 2018 Nov;11(11):1625-1636. doi: 10.1016/j.jcmg.2017.10.010. Epub 2017 Dec 13.
Results Reference
derived
Learn more about this trial
Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)
We'll reach out to this number within 24 hrs